Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: J Subst Abuse Treat. 2012 Jul 25;43(4):389–396. doi: 10.1016/j.jsat.2012.06.001

Table 1.

Description of measures of the quality of chronic disease management (CDM)care for alcohol and other drug (AOD) dependence

Definition Analytic sample Exposure
categories
Engagementa At least 2 visits to the CDM
clinic within 30 days of
initiation of care
(initiation=2 visits within 14
days of study enrollment)
Subjects with any
follow-up data (n=553)b
Engagement
No engagement
No access to
theCDM clinic
PACIC-CDM
clinicC
Measure of the degree that
care delivered by the CDM
clinic is aligned with core
components of the chronic
care model C
Subjects assigned access
to the CDM clinic with
12-month follow-up
data (n=249) d
PACIC-CDM
clinic summary
score (tertiles)
PACIC-anye Measure of the degree that
care for addictions delivered
by any healthcare provideris
aligned with core
components of the chronic
care model
Subjects who received
any care for addictions
from anyhealthcare
provider since study
enrollment with 12-
month follow-up data
(n=451) f
PACIC summary
score (tertiles)
a

Based upon the Washington Circle measure of treatment engagement

b

Alcohol and drug addiction severity analyses limited to subjects with alcohol dependence (“alcohol subsample”) n=409 and drug dependence (“drug subsample”) n=458, respectively.

C

Patient Assessment of Chronic Illness Care (PACIC)

d

Alcohol subsample: n=184 and Drug subsample: n=208

e

Any care for alcohol or other drug problems includes counseling, medication, groups or other treatments provided in any healthcare setting, such as detox, hospital, emergency room, or office by any healthcare provider, including doctors, nurses, social workers, or counselors.

f

Alcohol subsample: n=320 and Drug subsample: n=378